Press release
Darbepoetin Alfa (Aranesp) Market Size Forecasted To Achieve $7.51 Billion By 2029 With Steady Growth
Darbepoetin Alfa (Aranesp)
What Is the Darbepoetin Alfa (Aranesp) Market Size and Projected Growth Rate?
The Darbepoetin Alfa (Aranesp) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Darbepoetin Alfa (Aranesp) Market Size and Projected Growth Rate?
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12171
What Are the Major Segments in the Darbepoetin Alfa (Aranesp) Market?
The darbepoetin alfa (aranesp) market covered in this report is segmented -
1) By Type: Epogen, Procrit, Aranesp, Other Types
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Patients With Chronic Kidney Disease, Patients With Cancer, Other Applications
Subsegments:
1) By Epogen: Standard Formulations, Enhanced Formulations
2) By Procrit: Standard Formulations, Biosimilars
3) By Aranesp: Single-Dose Vials, Multi-Dose Vials
4) By Other Types: Combination Therapies, Alternative Erythropoiesis-Stimulating Agents
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12171&type=smp
What Are The Driving Darbepoetin Alfa (Aranesp) Market Evolution?
The darbepoetin alfa market's growth is anticipated to be fueled by the escalating prevalence of chronic ailments. These diseases, which often worsen over time, typically persist for more than three months. Darbepoetin alfa has been shown to be effective in treating a variety of these long-term ailments, in addition to countering anemia triggered by cancer chemotherapy. For example, in June 2024, the Australian Institute of Health and Welfare-a statutory authority of the Australian Government-reported that chronic diseases caused 171,500 fatalities in 2022. This was equivalent to 90% of all deaths that year, amounting to a rate of 659 per every 100,000 individuals. While it dipped to 448 per 100,000 in 2020, the age-standardized death rate due to chronic conditions subsequently rose to 459 in 2021 and 490 in 2022. Consequently, the escalating prevalence of chronic diseases is propelling the darbepoetin alfa market's expansion.
Which Firms Dominate The Darbepoetin Alfa (Aranesp) Market Segments?
Major companies operating in the darbepoetin alfa (aranesp) market include Johnson & Johnson, Amgen Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Serum Institute of India Pvt. Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Biocon Ltd., Reliance Life Sciences, Torrent Pharmaceuticals Ltd., 3SBio Inc., Cadila Healthcare Ltd., Dong-A ST Co. Ltd., Chong Kun Dang Holdings, Hetero Drugs Ltd., Intas Pharmaceuticals Ltd., Avesthagen Pharma, Stada Arzneimittel AG, Ranbaxy Laboratories Ltd., Sandoz International GmbH, Shandong Kexing Bioproducts Co. Ltd., Kyowa Kirin Co. Ltd., Polifarma S.p.A.
What Trends Are Expected to Dominate the Darbepoetin Alfa (Aranesp) Market in the Next 5 Years?
One prominent trend observed in the darbepoetin alfa market is product innovation. Key players in the market are embracing cutting-edge technologies to maintain their competitiveness. For example, in February 2023, GlaxoSmithKline Ltd., a leading pharmaceutical and biotechnology company based in the UK, launched Jesduvroq (daprodustat), which received approval from the US Food and Drug Administration (FDA). This medication, essentially darbepoetin alfa, also referred to as recombinant human erythropoietin or epoetin alfa, is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. It is prescribed as a daily treatment for anemia resulting from chronic kidney disease (CKD) in patients who have been on dialysis for a minimum of four months.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/darbepoetin-alfa-aranesp-global-market-report
Which Is The Largest Region In The Darbepoetin Alfa (Aranesp) Market?
North America was the largest region in the darbepoetin alfa (Aranesp) market in 2024. The regions covered in the darbepoetin alfa (Aranesp) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Darbepoetin Alfa (Aranesp) Market?
2. What is the CAGR expected in the Darbepoetin Alfa (Aranesp) Market?
3. What Are the Key Innovations Transforming the Darbepoetin Alfa (Aranesp) Industry?
4. Which Region Is Leading the Darbepoetin Alfa (Aranesp) Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Darbepoetin Alfa (Aranesp) Market Size Forecasted To Achieve $7.51 Billion By 2029 With Steady Growth here
News-ID: 3996934 • Views: …
More Releases from The Business Research Company
Increasing Demand For Personal Care And Cosmetic Products Drives Coconut Oil Mar …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Coconut Oil Market Size By 2025?
In the last few years, the coconut oil market has experienced substantial growth. The market size is projected to rise from $5.03 billion in 2024 to $5.49 billion in 2025, which is an annual compound growth rate (CAGR) of 9.2%. This growth in the…
Driving Cloud Security Market Growth in 2025: The Role of Countering The Surge I …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Cloud Security Market Size Growth Forecast: What to Expect by 2025?
The size of the cloud security market has notably increased over the past few years. The market is projected to expand from a value of $17.11 billion in 2024 to reach $19.71 billion in 2025, representing a compound annual growth rate (CAGR) of…
Comprehensive Cloud Based Contact Center Market Forecast 2025-2034: Growth Trend …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Cloud Based Contact Center Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The expansion in the cloud based contact center market has been substantial in the past few years. Its market size is projected to rise from $26.36 billion in 2024 to $31.04 billion in 2025, escalating at a compound…
Explosive Growth In The Consumer Electronics Fuels Circuit Protection Market: Po …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Circuit Protection Market Through 2025?
In recent times, the circuit protection market has experienced significant expansion. The market, which was valued at $54.5 billion in 2024, is projected to rise to $59.88 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%. Factors contributing to…
More Releases for Aranesp
Darbepoetin Alfa Market 2022 - 2030: Current and Future Opportunities for Key Pl …
The latest Release from "Stratagem Market Insights" is titled "Darbepoetin Alfa Market Research Report 2022-2030", This Market report offers qualitative and quantitative insights as well as a thorough examination of the market size and expansion rate of all potential market segments. The report has been put together using primary and secondary research methodologies, which offer an exact and detailed understanding of the market. The research report on the Darbepoetin…
Epoetin-alfa Erythropoietin Market Research Report 2022- Sales, Revenue, Size, T …
Epoetin alfa is a human erythropoietin produced in cell culture using recombinant DNA technology.Authorised by the European Medicines Agency on 28 August 2007, it stimulates erythropoiesis (increasing red blood cell levels) and is used to treat anemia, commonly associated with chronic kidney failure and cancer chemotherapy.Epoetin is manufactured and marketed by Amgen under the trade name Epogen. Johnson & Johnson subsidiary Janssen Biotech (formerly Ortho Biotech Products, LP), sells the…
Darbepoetin Alfa Market Update and Forecast to 2025; Johnson & Johnson, Novartis …
MarketInsightsReports has published a report titled global Darbepoetin Alfa Market research report 2020 that is a detailed observation of several aspects, including the rate of growth, technological advances and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market.
Over…
Global Darbepoetin Alfa Market – Amgen, Johnson & Johnson, Kyowa Hakko Kirin, …
According to a comprehensive study by KD Market Insights analyzes and forecasts the Darbepoetin Alfa Market at both global and regional level. The report provides an analysis of 6 years, in which 2017 is the base year, 2018 as an estimated year and 2019-2023 is forecasted period. The report consists of overall market size in 2017 and its anticipated growth in further 6 years. It gives grasp about the high…
Darbepoetin Alfa Market - North America is the Largest Consumption Place, with a …
This study researches the market size of Darbepoetin Alfa in United States, European Union and China, presents the Darbepoetin Alfa sales, revenue, market share and growth rate by companies, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key…
Global Darbepoetin Alfa Market-consumers Analysis Offers End to End Solutions to …
This report studies Darbepoetin Alfa in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.
Free | Request Sample Copy of the Report @ https://bit.ly/2LIw5st
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Amgen (Procrit, Aranesp,Epogen)
…
